Strong SARS-CoV-2 T-Cell Responses after One or Two COVID-19 Vaccine Boosters in Allogeneic Hematopoietic Stem Cell Recipients.

Clémenceau, Béatrice; Le Bourgeois, Amandine; Guillaume, Thierry; Coste-Burel, Marianne; Peterlin, Pierre; Garnier, Alice; Jullien, Maxime; Ollier, Jocelyn; Grain, Audrey; Béné, Marie C; Chevallier, Patrice

Clémenceau, Béatrice; Le Bourgeois, Amandine; Guillaume, Thierry; Coste-Burel, Marianne; Peterlin, Pierre; Garnier, Alice; Jullien, Maxime; Ollier, Jocelyn; Grain, Audrey; Béné, Marie C; Chevallier, Patrice.

Afiliação

Clémenceau B; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, F-44000 Nantes, France.
Le Bourgeois A; Hematology Department, Nantes University Hospital, F-44000 Nantes, France.
Guillaume T; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, F-44000 Nantes, France.
Coste-Burel M; Hematology Department, Nantes University Hospital, F-44000 Nantes, France.
Peterlin P; Virology Department, Nantes University Hospital, F-44000 Nantes, France.
Garnier A; Hematology Department, Nantes University Hospital, F-44000 Nantes, France.
Jullien M; Hematology Department, Nantes University Hospital, F-44000 Nantes, France.
Ollier J; Hematology Department, Nantes University Hospital, F-44000 Nantes, France.
Grain A; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, F-44000 Nantes, France.
Béné MC; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, F-44000 Nantes, France.
Chevallier P; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, F-44000 Nantes, France.

Cells ; 11(19)2022 09 27.

Article em En | MEDLINE | ID: mdl-36230971

Assuntos

COVID-19; Transplante de Células-Tronco Hematopoéticas; Vacinas; Vacina BNT162; COVID-19/prevenção & controle; Vacinas contra COVID-19; Transplante de Células-Tronco Hematopoéticas/métodos; Células-Tronco Hematopoéticas; Humanos; Imunização Secundária; SARS-CoV-2; Linfócitos T; Vacinas Sintéticas; Vacinas de mRNA

Palavras-chave

COVID-19; allogeneic hematopoietic stem cell transplantation; anti-SARS-CoV-2 vaccines; booster; cellular immunity; humoral immunity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Transplante de Células-Tronco Hematopoéticas / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google